Skip to content

Author

Wangxi Hai

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Tunable 18F-Labeling of Erlotinib-Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy.

Small molecule nanodrugs (SMNs) offer unique advantages for cancer therapy, yet accurately tracking their in vivo fate without perturbing their native assembly remains challenging. Here, we report a spacer engineering strategy that enables efficient 1 8F-labeling while preserving SMNs self-assembly. Erlotinib-based amp...

Jia-Feng Li, Yi-Ru Jiang, Ji-Wei Cui et al. · 0 citations
Sep 2026

FAP-targeted gold nanocluster-mediated radioligand therapy in combination with TGF-βRI inhibition for tumor therapy.

Targeted radioligand therapy (TRT) is an emerging treatment modality that selectively delivers radioisotopes to tumors while sparing healthy tissues. However, optimizing TRT radiopharmaceuticals to concurrently achieve sustained tumor retention and rapid systemic clearance remains a fundamental challenge. Gold nanoclus...

Hui-Zhen Yang, Liu Liu, Guoping Jia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.